prof. dr. J.P.G. (Joost P.G.) Sluijter

prof. dr. J.P.G. (Joost P.G.) Sluijter

Full Professor
prof. dr. J.P.G. (Joost P.G.) Sluijter
  • Onderzoek Cardiovasculair Reg. Med.



Prof Joost Sluijter is a Medical Biologist and got his PhD in 2004 at the University Utrecht on “Collagen turnover in arterial disease”. After being a postdoctoral research fellow at Indiana University-Purdue University (IUPUI), he returned to the University Medical Centre Utrecht (the Netherlands) in 2006.  In his research group, they focus on stimulating cardiac regeneration, thereby using approaches that can lead to improved recovery of cardiac tissue upon injury. In recent years, they identified miRNAs that can push cell lineage specifications and how they could improve progenitor cell transplantation, specifically improving local delivery and cell retention. In this work, they have started to use 3D-bioprinting and advanced technologies of cardiac tissue engineering. His group substantially improved cell delivery to the myocardium, from which they also realized that most of the injected cell action was due to the potential paracrine actions. They therefore started to study the use of secreted vesicles by these cells as a novel approach to induce cardiac repair.

Prof Joost Sluijter is heading the Experimental Cardiology Laboratory and is nucleus member of the Regenerative Medicine program of the UMCU, he is nucleus member of the ESC working groups Cellular Biology of the Heart and Cardiovascular Regenerative & Reparative Medicine, has several editorial roles for journals, published >170 papers, and is awardee of an ERC consolidator grant.

Side Activities

  • Nucleus member working group on Cellular Biology of the Heart (European Society of Cardiology)

  • Immediate past-Chair working group on Cellular Biology of the Heart (European Society of Cardiology)

  • Nucleus member working group on Cardiovascular Regenerative & Reparative Medicine (European Society of Cardiology)

  • Board member of the Council on Basic Cardiovascular Science (European Society of Cardiology)

  • Associate editor of Journal of Cardiovascular Translational Research

  • Associate Editor Discovery Biology and Medicine 

  • Editorial Board memeber of Clinical and Translational Physiology (Frontiers in Physiology)                                   

  • Editorial Board member of Non-coding RNA Investigation

  • Scientific reviewer for journal (selected): Arterioslerosis, Thrombosis and Vascular biology (ATVB),   American Journal of Physiology, British Journal of Pharmacology, Cardiovascular research (Card Res), Circulation (Circ), Circulation research (Circ Res), Clinical Science, Current Pharmaceutical Design, European Heart Journal (EHJ), Journal of the American College of Cardiology (JACC), Journal of Cellular and Molecular Medicine (JCMM), New England Journal of Medicine (NEJoM), Physiological Genomics, Plos One, Stem Cells International, Science.

  • Scientific reviewer for grant providers (selected): Dutch Heart Foundation, NWO, Foundation de Cooperation Scientifique Campus Paris Saclay (FCS, France), Health and Medical Research Fund (China), Danish Council for Independent Research, National Center of Science and Technology Evaluation (Kazachstan), Medical Research Council (UK), Sir Henry Dale Fellowship (UK), Science foundation of Ireland

  •  Lecturer teaching program of undergraduate students at the Faculty of Medicine, Utrecht University.

  • University Utrecht - advisory board for ERC Starting and consolidator Grant-candidates

  • Advisory Board van de Graduate School of Life Sciences University Utrecht

Fellowship and Awards

  • 2004-2005 Interuniversity Institute of the Netherlands (ICIN)-fellowship
  • 2007-2009 Novartis Foundation for Cardiovascular Excellence Grant
  • 2008-2009 van Ruyvenstichting
  • 2009-2012 UMC Utrecht focus and mass area “cardiovascular research”
  • 2010-2014 BMM-YIC
  • 2011-2015 Translationeel Adult Stamcelonderzoek:
  • 2012-2017 HUMAN STem cells for CArdiac REpair (HUSTCARE)
  • 2014-2018 LSH Impuls: MIGRATE
  • 2015-2017: BMM Smartcare2 – Smart microtissues for cardiac regeneration
  • 2015-2019: Horizon 2020 – TECHNOBEAT (PHC-16-2015)
  • 2015-2018: CAS-NWO Program; Cardiac cell therapy in a preclinical animal model for hereditary cardiomyopathy
  • 2017-2022: Horizon 2020 - ERC-2016-CoG – 725229:  EVICARE: Extracellular Vesicle-Inspired CArdiac Repair
  • 2017-2019: Vrienden UMCU: “Innovatieve directe medicijnafgifte in het hart”
  • 2018-2022 – Horizon 2020 Marie S. Curie, COFUND programme RESCUE: Local Training Network on REgenerative medicine and Stem Cell technology in UtrEcht 
  • 2018-2021: Technology Of Protein delivery through Extracellular Vesicles to target PCSK9 (TOP-EV), Dutch Heart Foundation 
  • 2019-2024: RegMed XB Cardiovascular Moonshot 
  • 2019-2024: Horizon 2020 BRAV3 (SC1-BHC-07-2019)
  • 2020-2021: NL-PET - Next Level genome editing - efficient and precise correction of PLN/R14del using Prime Editing Technology. PLN foundation


Research Output (275)

COVID-19-related cardiac complications from clinical evidences to basic mechanisms:Opinion paper of the ESC Working Group on Cellular Biology of the Heart

Pesce Maurizio, Agostoni Piergiuseppe, Bøtker Hans Erik, Brundel Bianca, Davidson Sean M., Caterina Raffaele De, Ferdinandy Peter, Girao Henrique, Gyöngyösi Mariann, Hulot Jean Sebastien, Lecour Sandrine, Perrino Cinzia, Schulz Rainer, Sluijter Joost Pg, Steffens Sabine, Tancevski Ivan, Gollmann-Tepeköylü Can, Tschöpe Carsten, Linthout Sophie Van, Madonna Rosalinda 1 sep 2021, In: Cardiovascular research. 117 , p. 2148-2160 13 p.

Targeting inflammation after myocardial infarction:A therapeutic opportunity for extracellular vesicles?

Viola Margarida, de Jager Saskia C.A., Sluijter Joost P.G. 1 aug 2021, In: International journal of molecular sciences. 22 , p. 1-17 17 p.

Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models

Demkes Evelyne J., Wenker Steven, Silvis Max J.M., van Nieuwburg Martijn M.J., Visser M. Joyce, Jansen Marlijn S., Brans Maike A.D., Velema Evelyn, Sluijter Joost P.G., Hoefer Imo E., de Kleijn Dominique P.V., Timmers Leo, de Jager Saskia C.A. 26 jul 2021, In: Frontiers in Pharmacology. 12 11 p.

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions:A Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Bulluck Heerajnarain, Paradies Valeria, Barbato Emanuele, Baumbach Andreas, Bøtker Hans Erik, Capodanno Davide, De Caterina Raffaele, Cavallini Claudio, Davidson Sean M., Feldman Dmitriy N., Ferdinandy Péter, Gili Sebastiano, Gyöngyösi Mariann, Kunadian Vijay, Ooi Sze Yuan, Madonna Rosalinda, Marber Michael, Mehran Roxana, Ndrepepa Gjin, Perrino Cinzia, Schüpke Stefanie, Silvain Johanne, Sluijter Joost P.G., Tarantini Giuseppe, Toth Gabor G., Van Laake Linda W., Von Birgelen Clemens, Zeitouni Michel, Jaffe Allan S., Thygesen Kristian, Hausenloy Derek J. 14 jul 2021, In: European heart journal. 42 , p. 2630-2642 13 p.

A Roadmap to Cardiac Tissue-Engineered Construct Preservation:Insights from Cells, Tissues, and Organs

Sampaio-Pinto Vasco, Janssen Jasmijn, Chirico Nino, Serra Margarida, Alves Paula M, Doevendans Pieter A, Voets Ilja K, Sluijter Joost P G, van Laake Linda W, van Mil Alain 28 mei 2021, In: Advanced materials. 33 , p. 1-24

Combined meta-analysis of preclinical cell therapy studies shows overlapping effect modifiers for multiple diseases

Zwetsloot Peter Paul, Antonic-Baker Ana, Gremmels Hendrik, Wever Kimberley, Sena Chris, Jansen Of Lorkeers Sanne, Chamuleau Steven, Sluijter Joost, Howells David W. 19 apr 2021, In: BMJ Open Science. 5 , p. 1-15 15 p.

Cardiac circadian rhythms in time and space:The future is in 4D

Chirico Nino, Van Laake Linda W, Sluijter Joost P G, van Mil Alain, Dierickx Pieterjan apr 2021, In: Current Opinion in Pharmacology. 57 , p. 49-59 11 p.

miR-132/212 Impairs Cardiomyocytes Contractility in the Failing Heart by Suppressing SERCA2a

Lei Zhiyong, Wahlquist Christine, el Azzouzi Hamid, Deddens Janine C., Kuster Diederik, van Mil Alain, Rojas-Munoz Agustin, Huibers Manon M., Mercola Mark, de Weger Roel, Van der Velden Jolanda, Xiao Junjie, Doevendans Pieter A., Sluijter Joost P.G. 19 mrt 2021, In: Frontiers in cardiovascular medicine. 8 14 p.

Angiotensin II-induced muscle atrophy via PPAR gamma suppression is mediated by miR-29b

Li Jin, Yang Tingting, Sha Zhao, Tang Haifei, Hua Xuejiao, Wang Lijun, Wang Zitong, Gao Ziyu, Sluijter Joost P.G., Rowe Glenn C., Das Saumya, Yang Liming, Xiao Junjie 5 mrt 2021, In: Molecular Therapy - Nucleic Acids. 23 , p. 743-756 14 p.

Advanced in Vitro Modeling to Study the Paradox of Mechanically Induced Cardiac Fibrosis

Bracco Gartner Thomas C.L., Stein Jeroen M., Muylaert Dimitri E.P., Bouten Carlijn V.C., Doevendans Pieter A., Khademhosseini Ali, Suyker Willem J.L., Sluijter Joost P.G., Hjortnaes Jesper 6 jan 2021, In: Tissue engineering. Part C, Methods. 27 , p. 100-114 15 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet